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Summary 
The immunodominant epitope of myelin basic protein, 
Ad -9, is encephalitogenic in H-2” mice. We have pre- 
viously demonstrated that this epitope displays low 
affinity for I-A” and have suggested that the avidity of 
T cell recognition in the thymus may be compromised, 
enabling autoreactive T cells to escape self-tolerance. 
We have addressed this hypothesis directly by con- 
structing transgenic mice expressing an encephalito- 
genie T cell receptor (TCR). Parenteral admininstration 
of Acl-9 had no discernable impact on developing thy- 
mocytes. In contrast, peptide analogs displaying far 
higher affinity for I-A”, provoked deletion of CD4 + CD8 + 
cells and transient down-regulation of the TCR by ma- 
ture CD4+CD8- thymocytes. The use of analogs of in- 
termediate affinity permitted a margin of error to be 
defined for the induction of tolerance and confirmed 
that the affinity of Acl-9 lies well below the critical 
threshold. 
Introduction 
The phenomenon of autoreactivity suggests that immuno- 
logical self-tolerance is far from absolute, sparing some 
T cells in spite of their anti-self mandate. Accordingly, T 
cells specific for various self-components may be readily 
detected in the periphery of otherwise healthy individuals 
and laboratory animals (Schluesener and Wekerle, 1985; 
Karachunski et al., 1994). Several strategies have been 
proposed to explain how such autoaggressive T cells pass 
undetected during repertoire selection in the thymus. Pre- 
sentation of an autoantigen at a concentration too low to 
promote self-tolerance has been invoked for some self- 
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proteins (Cibotti et al., 1992) and may contribute to the 
poor tolerogenicity of thyroglobulin, one of the autoanti- 
gens implicated in the aetiology of thyroiditis (Dawe et al., 
1993). In contrast, the cryptic epitopes of an autoantigen 
may never be presented intrathymically due to limitations 
inherent in antigen processing (Mamula, 1993); the erro- 
neous induction of enzymes not normally involved in pro- 
cessing may, however, secure their presentation in the 
periphery, where T cell activation may ensue. Alterna- 
tively, sequestration of self-components in an immunologi- 
cally privileged site, such as the anterior chamber of the 
eye, may likewise prevent their presentation to developing 
thymocytes. 
It is commonly believed that the blood-brain barrier is 
responsible for rendering the CNS just such a secluded 
site from which potential autoantigens are denied access 
to the thymic microenvironment. The consequent inability 
of negative selection to purge the peripheral repertoire of 
T cells specific for self-components such as myelin basic 
protein (MBP) may be readily demonstrated in susceptible 
strains of experimental animals: administration of either 
spinal cord homogenate or purified MBP in an immuno- 
genie fashion results in the inflammatory condition, experi- 
mental autoimmune encephalomyelitis (EAE), bearing 
many of the hallmarks of multiple sclerosis in humans. 
Although the sequestration of MBP is widely believed to 
contribute to the lack of self-tolerance to this autoantigen, 
lymph draining the CNS is known to carry such proteins 
to the lymphoid tissue (Cserr and Knopf, 1992) where it 
may be presented to both the developing and peripheral 
Tcell repertoire. Furthermore, recent studies havedemon- 
strated that MBP is expressed in the fetal thymus from the 
earliest stages of ontogeny (Pribyl et al., 1993; Mathisen 
et al., 1993) consistent with its full participation in the 
induction of self-tolerance. Our recent characterization of 
an immunodominant epitopeof MBP hassuggested apos- 
sible solution to this paradox. 
Encephalitogenic T cells from H-2” mice recognize the 
acetylated N-terminal peptide of MBP, Acl-9 (Zamvil et 
al., 1986). We and others have recently demonstrated that 
this epitope displays very low affinity for its restriction ele- 
ment, I-A”, forming an interaction so transient as to prevent 
the measurement of its half-life in vitro (Fairchild et al., 
1993; Mason and McConnell, 1994; Mason et al., 1995). 
This low affinity is a function of the principal anchor resi- 
due, Lys4, which, being nonhydrophobic and of limited 
size, fits poorly into the major hydrophobic pocket of I-A” 
(Fairchild et al., 1994). These findings suggest that the 
low affinity interaction between Acl-9 and class II MHC 
may undermine the efficacy of its presentation in vivo, 
enabling autoreactive T cells to escape self-tolerance. We 
have tested this hypothesis directly by constructing mice 
transgenic for an encephalitogenic TCR and assessing 
the impact on the developing T cell repertoire of either 
Acl-9 or peptide analogs designed to exhibit higher affin- 
ity for I-A”. 
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Characterization of Mice Transgenic for an 
Encephalitogenic TCR 
Rearranged a and p TCR chain genes were generated by 
polymerase chain reaction (PCR) amplification of cDNA 
from 1934.4, an Acl-S-specific T cell hybridoma derived 
from an encephalitogenic Tcell clone (Wraith et al., 1989). 
Expression of the Vu4 and Vf38.2 transgenes was directed 
by the human CD2 regulatory elements so as to achieve 
T cell-specific expression, independent of the site of inte- 
gration (Greaves et al., 1989). Two linesof transgenic mice 
were isolated, differing only in their level of TCR expres- 
sion, while CD4+CD8+ thymocytes from Tg3 mice ex- 
pressed the transgene at levels only marginally above 
those of nontransgenic littermates, mice of the Tg4 line 
expressed TCR at levels significantly greater than physio- 
logical, displaying values of mean channel fluorescence 
three times higher than those of Tg3 thymocytes (Figures 
1A and 16). The thymicT cell repertoire of either line back- 
crossed onto PUJ (H-2”) mice was found to be heavily 
skewed towards cells of the CD4’ phenotype, SO%-95% 
of which expressed Vp8.2 (data not shown). Interestingly, 
while 25%-30% of thymocytes from Tg3 mice were rou- 
tinely of a mature CD4+CD8- phenotype, this same subset 
represented approximately 60% of all thymocytes in mice 
of the Tg4 line, suggesting that higher copy numbers of 
the TCR transgene may favor positive selection. 
Mice of either line were found to be sensitive to the 
induction of EAE, some animals of the Tg4 line suc- 
cumbing to disease, even after administration of Acl-9 
in the absence of pertussis toxin (Table 1). These results 
are therefore in contrast with those obtained using similar 
TCR transgenic mice, produced in other laboratories (Gov- 
erman et al., 1993; Lafaille et al., 1994). Such mice have 
been found to develop spontaneous EAE. Indeed, one 
such line (Goverman et al., 1993) reared in isolators in 
parallel with our own trangenics, showed a 100% inci- 
dence of EAE among male mice and an incidence as high 
as 50% among females; our own animals, in contrast, 
remained consistently healthy (data not shown). 
Figure 1. Characterization of Transgenic Mice of the Tg3 and Tg4 
Lines 
(A-B) Expression of the V88.2 transgene by CD4+CD8+ thymocytes 
from Tg3 (open histogram) and Tg4 mice (closed histogram) (A) com- 
pared with levels of expression among thymocytes from wild-type lit- 
termates (B). Values of mean channel fluorescence were 99 and 302 
for Tg3 and Tg4 mice, respectively, compared with a value of 70 for 
wild-type thymocytes. 
(C-D) Responsiveness of unprimed transgenic T cells to analogs of 
Acl-9 differing only in their affinity for I-A”‘. (C) Unprimed T cells from 
Tg3 mice were challenged in vitro with varying concentrations of pep- 
tide analogs and their responses measured 24 hr later. Splenocytes 
from Tg4 mice displayed a similar pattern of responsiveness, consis- 
tentlyresponding tolowerconcentrationsofeach peptide. (D)Competi- 
tion between peptide analogs and Biol-9[4Y] for binding to 1-A” at the 
surface of PL-8 cells, revealed by flow cytometric analysis. 
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Table 1. Suscepitibility of Transgenic Mice to Induction of EAE 
Non-transgenic littermates TN TM 
Median Mean Median Mean Median Mean 
day of maximal day of maximal day of maximal 
Treatment Incidence onset grade Incidence onset grade Incidence onset grade 
Pertussis Toxin 015 015 015 - 
Acl -9 015 - nt nt nt 2/5(1/5) 9, 27 1 .oo 
Acl-9 + Pertussis experiment 1 10110 11 2.2 8/8(1/E) 14 1.75 7/9(3/9) 11 2.78 
Acl-9 + Pertussis experiment 2 9/9(1/9) 11 2.55 7/8(3/E) 10 2.88 8/8(616) 10 4.25 
Age- and sex-matched mice were primed at the base of the tail with 200 ug of Acl-9 in CFA with or without the administration of pertussis toxin 
1 and 3 days later. Control mice received pertussis toxin alone. EAE was monitored daily for a minimum of 35 days and the mean maximal grade 
of disease was calculated based on both paralyzed and unaffected mice. 
nt, not tested. 
’ Numbers enclosed in parentheses denote the incidence of death. 
Influence of Residue 4 on MHC Binding and T Cell 
Activation 
Both Tg3 and Tg4 mice were found to mount vigorous 
primary responses in vitro to Acl-9 (Figure 1C). We have 
shown previously that lysine at position 4 of this peptide 
actsasthe principal anchor residue, since analogs bearing 
substitutions at this position for residues of greater hydro- 
phobicity display demonstrably higher affinity for I-A”, 
while an analog bearing alanine at this position (Acl- 
9[4A]) has been shown to exhibit an affinity for I-A” greater 
than ten times that of the wild-type peptide (Wraith et al., 
1989), the tyrosine-substituted analog (Acl-9[4Y]) dis- 
plays a far higher affinity, rivaled only by Acl-9[4V] (Fair- 
child et al., 1993). Each of these analogs elicited enhanced 
T cell responses in an affinity-dependent manner, the mini- 
mal concentration of each peptide required to provoke a 
maximal response closely mirroring its affinity for class 
II determinants, measured in competition binding assays 
(Figure 1 D). 
Previous studies of one of the two TCR contact residues 
of this peptide have shown that most substitutions at posi- 
tion 3 are nonpermissive, as few as 5 of the 20 possible 
analogs stimulating a cross-reactive response (Wraith et 
al., 1992). Interestingly, substitution of Lys with Tyr at posi- 
tion 4 of each of these analogs failed to modify the pattern 
of cross-reactivity observed, suggesting that residue 4 is 
solely concerned with class II binding, failing to contribute 
either directly or indirectly to interaction of the peptide with 
the encephalitogenic TCR. 
Effect of Acl-9[4Y] on Immature 
CD4 + CD8 + T hymocytes 
To determine whether transgenic thymocytes are suscep- 
tible to the induction of tolerance centrally within the thy- 
mus, mice of the Tg3 line were treated intraperitoneally 
with 100 ug of Acl-9[4Y] in phosphate-buffered saline 
(PBS) and the impact on thymocyte subsets was assessed 
at 4 hr intervals. Three-color flow cytometry was employed 
to determine expression of CD4, CD8, and the Vp8.2 
transgene. Figure 2 shows that the high affinity analog 
provoked marked deletion of CD4+CD8’ cells within 4 hr 
of treatment (Figure 28) the extent of clonal deletion be- 
coming most apparent by 16 hr when as few as 2.3% of 
cells retained a CD4+CD8+ phenotype (Figure 2D). Abso- 
lute numbers of thymocytes were also dramatically af- 
fected by administration of the peptide, there being a de- 
crease from an average of 5.8 x lo7 cells in untreated 
animals, to as few as 0.7 x 10’ thymocytes, 24 hr after 
treatment. Injection of 10 pg of Acl-9[4Y] likewise had a 
profound impact, while even 1 ug of the peptide provoked 
detectable levels of clonal deletion of immature thymo- 
cytes (data not shown), results that are consistent with 
findings from various other transgenic models (Murphy et 
al., 1990; Vasquez et al., 1992; Spain and Berg, 1992; 
Mamalaki et al., 1992) and that confirm the peculiar sensi- 
tivity of CD4+CD8+ cells to negative selection pressures 
(Rothenberg, 1994). In accordance with these findings, 
the intraperitoneal administration of Acl-9[4Y] had no dis- 
cernable effect on numbers of mature T cells in the periph- 
ery (data not shown). 
Effect of Acl-8[4Y] on Mature 
CD4+ CD8- Thymocytes 
Although mature CD4+CD8- thymocytes survived clonal 
deletion, we consistently observed the appearance of cells 
expressing a CD4r°CD8- phenotype (Figure 2D, arrow- 
head). Since this subset first appeared at 8 hr posttreat- 
ment, some time after the disappearance of CD4+CD8+ 
thymocytes (Figure 2C), such cells are most likely derived 
from the mature CD4+CD8- subset by the partial down- 
regulation of CD4. The mature status of these cells was, 
however, confirmed by an analysis of the early activation 
marker, CD69. Approximately 40% of CD4+CD8- cells 
from untreated mice expressed intermediate levels of 
CD69 (Figure 3A), consistent with their recent positive se- 
lection (Yamashita et al., 1993; Swat et al., 1993). Intra- 
peritoneal administration of 100 ug of Acl-9[4Y], how- 
ever, resulted in the rapid and universal up-regulation of 
CD69 to ten times its original level within 16 hr of treatment 
(Figure 38) reminiscent of the activation of mature T cells 
in the periphery. 
Consistent with this apparent activation, flow cytometric 
analysis of V88.2 expression by CD4+CD8- thymocytes 
revealed up-regulation of the encephalitogenic TCR to 
twice its normal level for up to 8 hr after treatment (see 
Figures 2H-21) although these kinetics varied slightly be- 
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Figure 2. Time Course of Clonal Deletion and 
TCR Modulation in Mice Treated with the High- 
est Affinity Peptide, Acl-9(4Y] 
Tg3 mice were injected intraperitoneally with 
100 pg of peptide and the thymus removed for 
phenotypic analysis either at time 0 (A and G). 
or at 4 hr (6 and H), 8 hr (C and I), 16 hr (D 
and J), 24 hr (E and K), or 4 days (F and L) 
posttreatment. Thymocytes were stained for 
three-color flow cytometry using anti-CD4-PE, 
anti-CDB-FITC, and biotinylated anti-V68.2 
(clone F23.1). Binding of F23.1 was visualized 
by the addition of streptavidin-Tricolor and 
10,000 events were analyzed. The CD4/CD8 
profile of thymocytes was assessed (A-F) and 
used to set a live acquisition gate around the 
CD4+CD8- subset for analysis of V68.2 expres- 
sion (G-L). The arrowhead identifies the 
CD4%D8- population defined as having a 
mean channel fluorescence less than 70. 
-CDB- - vpe - -CD8- 
tween experiments. Within 12-16 hr, however, a rapid 
down-regulation was observed in all mice treated with the 
peptide. The majority revealed two distinct populations 
of mature thymocytes differing markedly in their surface 
density of both CD3 and TCR; while 40%-50% of mature 
thymocytes resumed pretreatment levels of TCR expres- 
sion, the remainder down-regulated their receptors a fur- 
ther 5-fold (Figure 2J). Interestingly, while cells of either 
phenotype were equally represented among thymocytes 
expressing the highest levels of CD4 (Figures 4A-46) 
CD41° cells were found to belong exclusively to the TCFP 
subset (Figure 4C), suggesting that those cells that had 
reduced their expression of CD4 had also maximally down- 
regulated theencephalitogenicTCR. Importantly, thissub- 
set began to re-express the TCR at levels approaching 
physiological within 24 hrof treatment, coincident with the 
expected clearance of peptide from the circulation (Figure 
2K). Mature thymocytes were not uniquely susceptible to 
such fluxes in the expression of TCR, there being evidence 
8 
38.3 I B 1 96.9 
- CD69 - 
Figure 3. Expression of CD69 by CDQCDB- Thymocytes 
CD69 expression was assessed either (A) before, or (6) 16 hr after 
treatment with 100 ug of Acl-9[4Y]. Thymocyies were stained for 
three-color flow cytometry as described in Figure 2 with the exception 
that biotinylated anti-CD69 (clone H1.2F3) was used in place of anti- 
V68.2. CD4’CD8- cells (5,000) were analyzed for surface expression 
of CD69 by applying a live acquisition gate around the appropriate 
subset. 
- VP8 - 
of similar phenotypic changes among peripheral T cells 
following administration of Acl-9[4Y] (data not shown). 
In various transgenic models, the down-regulation of 
both CD8 and TCR ha8 been shown to maintain self- 
tolerance among peripheral class l-restricted T cells in 
response to continuous antigenic challenge (Schbnrich et 
al., 1991, 1992; Rocha and von Boehmer, 1991; Homer 
et al., 1993). Interestingly, the interaction of peripheral T 
cells with antigen has likewise been shown to result in a 
biphasic pattern of TCR expression (Ferber et al., 1994) 
the extent of down-regulation having been found to de- 
pend on the availability of antigen. This suggests that the 
- VP8 - 
Figure 4. Vf38.2 Expression by Mature Thymocytes Differing in their 
Levels of Expression of CD4 
Live gates were placed around the CD41°CD8- and CD4”CD8- subsets 
(A) defined as exhibiting a fluorescence intensity less than 70 channels 
or greater than 200 channels, respectively. Events (5,000) were ac- 
quired and the expression of VR8.2 by CD4”’ cells (6) was compared 
with that of thymocytes expressing low levels of CD4 (C). 
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TCRhi population, observed in our own experiments (see 
Figure 2J), may represent cells whose distribution within 
the thymus renders them inaccessible to peptide. Adminis- 
tration of Acl-9[4Y], however, results in activation of virtu- 
ally all CD4+CD8-thymocytesirrespective of their location, 
accompanied by the almost universal up-regulation of 
CD89 (see Figure 38) arguing strongly against such an 
explanation. Furthermore, the abundant expression of 
CD89 suggests that almost all CD4+CD8- thymocytes are 
antigen specific, and therefore express the clonotypic 
TCR, calling into question the possibility that the two popu- 
lationsof mature thymocytesmay bedistinguished bytheir 
expression of endogenous a chain in preference to the 
Vu4 transgene (Rocha and von Boehmer, 1991). Interest- 
ingly, the proportion of CD4+CD8- thymocytes down- 
regulating the encephalitogenicTCR toone-fifth its normal 
level was found to correlate approximately with the propor- 
tion of cells expressing CD89 prior to treatment (see Figure 
3A). This may imply that the TCR’O population represents 
those cells that have most recently undergone positive 
selection and that have yet to be rendered refractory to 
clonal deletion (Swat et al., 1993). 
Effect of Acl -9[4Y] on Reactivity of Mature 
CD4+ T Cells 
The state of reactivity of mature CD4’CD8- thymocytes 
was investigated in Tg3 mice following a single 100 ug 
dose of Acl-9[4Y]. Phenotypically mature thymocytes 
were purified using anti-CD8 plus complement and were 
cultured with mitomycin C-treated PUJ splenocytes in the 
presence of Acl-9. Figure 5A shows that such a regimen 
rendered mature thymocytes hyperresponsive to their 
cognate peptide compared with CD4+CD8- thymocytes 
from mice receiving PBS alone. A similar state of hyperres- 
ponsiveness was apparent among peripheral CD4+ T cells 
24 hr after treatment with Acl-9[4Y], but was found to be 
transient, the levels of responsiveness observed falling 
below control levels within 72 hr of treatment (Figure 5B). 
These kinetics may reflect the initial up-regulation of the 
encephalitogenic TCR prior to its subsequent down- 
regulation, as seen in earlier experiments. 
A profound state of nonresponsiveness was achieved 
among peripheral T cells by the chronic administration of 
Acl-9[4Y]; injection of 200 pg of peptide on 10 occasions 
2-3 days apart rendered cells incapable of responding 
to Acl-9 in vitro. In contrast, control mice receiving the 
I-E”-restricted MBP epitope, 31-47, responded normally 
to Acl-9 (Figure 5C). Although this state of nonrespon- 
siveness may refect the induction of anergy, we are pres- 
ently unable to exclude the preferential expansion of T 
cell clones bearing an endogenous a chain under these 
experimental conditions. 
Impact of the Wild-Type Peptide, Acl-9, on T Cell 
Repertoire Selection 
Having characterized the effects of Acl-9[4Y] on thymo- 
cytes and T cells at different stages of development, we 
next sought to determine whether analogs of lower affinity, 
and the wild-type peptide in particular, were capable of 
Figure 5. Responsiveness of Mature CD4+ Thymocytes and Periph- 
eral T Cells to Acl-9 following In Vivo Treatment with Ad-9[4Y] 
CD4’ thymocytes (A) and peripheral T cells (6 and C) were purified 
and cocultured with mitomycin C-treated PUJ splenocytes in the pres- 
ence of varying concentrations of Acl-9. Animals had been treated 
previously with either a single 100 pg dose of Acl-9[4Y] (A and S), 
or 10 successive doses of 200 ug at intervals of 2-3 days(C). Control 
mice were treated either with the I-E”-restricted epitope of LISP, 31- 
47, or PBS alone. 
provoking either clonal deletion or modulation of the TCR. 
Transgenic mice were therefore treated intraperitoneally 
with 100 ug of peptide analogs varying only in their affinity 
for I-A” and their impact on developing thymocytes was 
assessed 18 hr later when both clonal deletion and down- 
regulation of the TCR were expected to be most apparent 
(see Figures 2D and 2J). 
Administration of Acl-9[4Y] in PBS was again found 
to induce profound depletion of CD4+CD8+ thymocytes in 
mice of the Tg3 line, resulting in a decrease from 64.3% 
to 10.2% (Figure 6A). Acl-9[4V] likewise induced marked 
deletion of CD4+CD8+ cells (Figure 6B) in spite of dis- 
playing a relative affinity for I-A” lower than that of Acl- 
9(4Y]. Like this higher affinity peptide, Acl-9[4V] was also 
responsible for the partial down-regulation of both CD4 
(Figure 6B) and TCR (data not shown). In contrast, the 
Immunity 
412 
- CD8- 
Figure 6. The Effect of Peptide Analogs of Varying Affinity on 
Transgenic Thymocytes 
Tg3 mice were treated intraperitoneally with PBS containing 100 ug 
of Acl-9(4Y] (A), Acl-9(4V] (B), Acl-9[4A] (C), the wild-type epitope, 
Acl-9, (D) or the I-As-restricted peptide, 84-96 (E) and the thymus 
removed 16 hr later. Thymocytes were stained for expression of CD4 
and CD8 using PE-conjugated YTS191.1 and YTSl89.4-FITC and 
10,000 events were acquired for analysis. 
intermediate-affinity peptide, Acl-9[4A], provoked only 
marginal deletion in some but not all mice and failed to 
influence surface expression of the TCR and associated 
molecules(Figure6C). Furthermore, animals receiving the 
natural peptide, Acl-9, exhibited CD4/CD8 and TCR pro- 
files indistinguishable from those of control mice treated 
with 84-96, an I-AS-restricted epitope of MBP which fails 
to bind to I-AU (Wraith et al., 1990) (Figures 6D and 6E). 
Indeed, even treatment of Tg3 mice with three successive 
injections of up to 200 ug of Acl-9 over a 7 day period 
had no discernible effect on the thymus (data not shown). 
Table 2. Differential Sensitivity of Tg3 Thymocytes to Peptide-Induced Phenotypic Changes 
Phenotype Acl-9 Acl-9[4A] Acl -9[4Y] 
CD69 up-regulation by CD4+CD8- cells* f + + 
Clonal deletion of CD4+CD8’ thymocytesb + + 
TCR modulation by CD4+CD8- thymocytes” + 
a Plus/minus refers to a mean channel fluorescence of 200-300, while plus denotes a value greater than 300. 
b Plus/minus indicates a decrease in percentage of CD4+CD8+ cells from 63% to approximately 400% while plus denotes widespread deletion 
leaving a residual population of CD4+CD8’ cells of approximately 10%. 
c Minus refers to a value of mean channel fluorescence greater than 250, while plus implies down-regulation of the TCR to a mean channel of 
less than 100. 
In spite of representing the immunodominant epitope of 
MBP in H-2” mice, Acl-9 therefore fails to induce either 
clonal deletion of CD4+CD8+ cells or down-regulation of 
TCR and accessory molecules by mature CD4+CD8- thy- 
mocytes. Rather than remaining entirely inert, however, 
Acl-9 succeeded in securing the partial up-regulation of 
CD69 (data not shown), suggesting that CD4+CD8- thymo- 
cytes are more sensitive to such changes than they are 
to TCR modulation. Furthermore, the finding that partial 
deletion of CD4+CD8+ cells may occur independently of 
TCR modulation upon treatment with the intermediate- 
affinity analog, Acl-9(4A], suggests that thymocytes are 
more sensitive to clonal deletion than TCR modulation but 
less so than they are to changes in CD69 expression (Ta- 
ble 2). 
To determine the mechanism of deletion induced by 
higher affinity analogs, DNA was extracted from the thy- 
mocytes of treated mice and the generation of oligonu- 
cleosomal bands assessed by electrophoresis over a 2% 
agarose gel. Figure 7shows that both Acl-9[4Y] and Acl- 
9[4V] provoked marked degradation of the genome char- 
acteristic of apoptosis (lanes 4 and 5). In contrast, how- 
ever, Acl-9 and the control peptide 84-96 failed to induce 
antigen-driven cell death (Figure 7, lane 2). Interestingly, 
even the alanine-substituted peptide, bearing a lo-fold 
higher affinity for I-A”, was incapable of provoking 
apoptosis (Figure 7, lane 3). 
The Affinity of Acl-9[4A] Lies on the Threshold 
Required for the Induction of Tolerance 
Although the intermediate-affinity peptide, Acl-9[4A], 
failed to induce surface modulation of TCR and its acces- 
sory molecules, marginal deletion of CD4+CD8+ thymo- 
cytes was occasionally observed (see Figure 6C), albeit at 
levels insufficient to permit detection of oligonucleosomal 
bands (Figure 7, lane 3). These findings suggest that an 
affinity ten times that of the natural epitope may lie on 
the threshold required for tolerance induction. To test this 
hypothesis directly, 100 kg of Acl-9[4A] was administered 
intraperitoneally to transgenic mice of the Tg4 line, bearing 
3-fold higher levels of TCR. Of six such mice, five showed 
profound depletion of CD4+CD8+ cells (Figure 8A), while 
control mice of the Tg3 line were either unaffected by the 
peptide or exhibited low levels of clonal deletion (Figure 
8B). Importantly, a substantial population of CD4+CD8+ 
cells survived their encounter with the wild-type peptide 
(Figure 8C), there being only a modest decrease from an 
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Figure 7. Apoptosis Is the Mechanism of Clonal Deletion among 
CDQCDB’ Thymocytes 
The extent of fragmentation of DNA was assessed by sampling thymo- 
cytes from mice treated, as in Figure 5, with the control peptide, 84- 
96 (lane l), Acl-9 (lane 2), Acl-9[4A] (lane 3) Acl-9[4V] (lane 4) or 
Acl-9[4Y] (lane 5). Thymocytes (1 x 10s) were incubated for 2 hr at 
55% in 20 ul of lysis buffer before being applied to the wells of a 2% 
agarose gel. 
average of 27.4% in control mice to 20.30/o, based on 
findings from four individual animals treated with Acl-9: 
thus, administration of the natural peptide to Tg4 mice 
likewise fails to eliminate autoreactive thymocytes fully. 
Recent studies of T cell development have supported 
an avidity model of repertoire selection: while low avidity 
recognition of antigen may promote positive selection of 
immature thymocytes, interactions of high avidity have 
been shown to favor negative selection by clonal deletion 
(Ashton-Rickardt et al., 1994; Ashton-Rickardt and Tone- 
gawa, 1994; Sebzda et al., 1994). Various parameters are 
known to contribute to avidity, including the level of expres- 
sion of TCR and accessory molecules, and the affinity of 
the TCR for its ligand. Should either of these parameters 
be compromised, the avidity of T cell recognition may fall 
below the threshold required for negative selection, per- 
mitting autoreactive T cells to escape self-tolerance. Ac- 
cordingly, T cells surviving tolerance induction have been 
found to express low affinity receptors (Wood et al., 1987) 
or abnormally low levels of CD8 (Teh et al., 1989). 
A further parameter that contributes significantly to avid- 
ity is the density of peptide-Ml-K complexes presented 
within the thymus. Such densities may fail to reach the 
critical threshold required for negative selection if avail- 
ability of an autoantigen is restricted. Anatomical con- 
straints may prevent access to the thymus, while limita- 
tions inherent in antigen processing may render an epitope 
cryptic (Mamula, 1993; Gammon and Sercarz, 1989). The 
affinity of an autoantigenic epitope for its restriction ele- 
ment may likewise affect the density of complexes within 
the thymus, influencing the outcome of selection events. 
Figure 6. The Affinity of Acl-9[4A] Lies on the Threshold Required 
to Induce Clonal Deletion 
(A and 9) Acl-9(4A] has a differential effect on thymocytes from Tg4 
(A) or Tg3 (9) mice, differing only in their level of TCR expression. 
Mice were treated intraperitoneally with 100 ug of Acl-9]4A] and the 
expression by thymocytes of CD4 and CDB was assessed 16 hr later 
as described in Figure 5. 
(C)The wild-type peptide, Acl-9, has a limited impact on thymocytes 
from Tg4 mice, causing an average reduction in the percentage of 
CD4+CD8+ thymocytes from 27.4%20.3%. 
We have recently reported that the immunodominant epi- 
tope of MBP in H-2” mice displays an affinity for I-A” so 
low as to preclude the formation of stable complexes, sug- 
gesting a rational basis for the escape of encephalitogenic 
T cells from tolerance induction (Fairchild et al., 1993, 
1994; Mason and McConnell, 1994; Mason et al., 1995). 
Here, we provide direct evidence to support this hypoth- 
esis by showing that administration of supraphysiological 
levels of the natural epitope to mice bearing an encephali- 
togenicTCR has no obvious impact on repertoire selection 
in the thymus. Even the administration of Acl-9[4A), dis- 
playing a lo-fold higher affinity for I-A”, permits few autore- 
active T cells to be purged from the repertoire, highlighting 
the substantial margin of error involved. In marked con- 
trast, peptide analogs of still higher affinity provoke pro- 
found deletion of CD4+CD8+ cells. These results are signif- 
icant in view of recent findings indicating that low affinity 
for class II is a property shared by autoantigenic epitopes 
from a number of self-proteins (Joosten et al., 1994); the 
failure to promote clonal deletion at the CD4’CDB’ stage 
of differentiation may, therefore, be involved in the aetiol- 
ogy of various autoimmune conditions. 
Our experiments using Acl-9[4A] in transgenic mice of 
the Tg4 line provide further support for an avidity model 
of thymic selection. Higher levels of the TCR are able to 
compensate for the low affinity of the autoantigen, thereby 
provoking widespread clonal deletion. The outcome of thy- 
mic selection is likewise skewed in favor of clonal deletion 
in mice expressing abnormally high levels of CD8, en- 
immunity 
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coded both endogenously as well as by means of a 
transgene (Robey et al., 1992). These findings suggest 
that the various parameters governing the avidity of T cell 
recognition determine the fate of autoreactive thymocytes, 
either ensuring their submission to self-tolerance or fa- 
voring their ultimate escape. 
Experimental Procedures 
Transgenic Mice 
TCR transgenic mice were obtained using standard approaches to 
transgenesis. In brief, the TCR a and 5 transgenic constructs were 
generated by inserting appropriate cDNAs containing the leader and 
coding sequences into the human CD2 minigene (Greaves et al., 
1989). RNA splice sites and a poly(A) signal sequence were introduced 
by ligating a genomic segment of the human f3-globin gene 3’ to the 
TCR sequence. The final constructs were injected at equimolar con- 
centrations into (CBA x BlO)F2 fertilized eggs and the founder mice 
backcrossed onto a PUJ (H-2”) background. All animals were main- 
tained under specific pathogen-free conditions at Central Biomedical 
Services, University of Cambridge, in accordance with institutional 
guidelines. 
Peptides 
All peptides were based on the acetylated N-terminal sequence of 
murine MBP (AC-ASQKRPSQR), with the exception of the 64-96 epi- 
tope, whose sequence is as follows: VHFFKNIVTPRTP. Analogs of 
Acl-9 displaying higher affinity for I-A” were constructed by the substi- 
tution of the wild-type Lys at position 4 for either Ala, Val, or Tyr. These 
peptides were synthesized using standard Fmoc chemistry on an LKB 
Biolynx 4175 synthesizer as described in detail elsewhere (Fairchild 
et al., 1993). The biotinylated probe, Biol-9[4Y], was likewise based 
on the l-9 sequence of MBP but with the addition of Gly and Tyr 
spacer residues at the N terminus. This extended peptide was biotinyl- 
ated prior to cleavage from the resin using a long chain derivative of 
NHS-biotin (Calbiochem), thereby inserting a 14 atom spacer between 
the biotin and the N-terminal amino group. 
Induction of EAE 
Age- and sex-matched mice were primed subcutaneously at the base 
of the tail with 200 ug of Acl-9 in 0.1 ml of a sonicated emulsion 
consisting of an equal volume of complete Freund’s adjuvant (CFA) 
and PBS containing 4 mglml of heat-killed Mycobacterium tuberculo- 
sis, strain H37RA (Difco Laboratories). On days 1 and 3 postimmuniza- 
tion, 200 ng of pertussis toxin (Porton Products) were administered 
intraperitoneally in 0.5 ml of PBS. Alternatively, mice were injected 
with Acl-9 in CFA or pertussis toxin alone. EAE was monitored daily 
thereafter for 35-50 days, The severity of EAE was assessed as fol- 
lows: (1) flaccid tail; (2) partial hindlimb paralysis and impaired righting 
reflex; (3) total hindlimb paralysis; (4) fore- and hindlimb paralysis; 
moribund. 
Proliferation Assays 
The responsiveness of unprimed transgenic T cells to Acl-9 and its 
analogs was determined by culturing unfractionated splenocytes from 
Tg3 mice at 3 x lo5 cells per well in IMDM medium (GIBCO) supple- 
mented with 1% fetal calf serum (Flow Laboratories), 2mM L-glutamine 
(GIBCO), 5 x 10m5 M 2-mercaptoethanol, 100 U/ml penicillin, and 100 
uglml streptomycin. Peptides were titrated into cultures and individual 
wells were pulsed after 24 hr with 0.5 pCi of PHI-TdR (Amersham 
International); levels of incorporation were assessed a further 24 hr 
later and the results plotted as the arithmetic mean of triplicate cultures 
f standard deviation. 
The reactivity of CD4+CD6- thymocytes to Ad-9 following in vivo 
treatment with Acl-9[4Y] was ascertained by preparing single cell 
suspensions of thymocytes and depleting residual CD4+CD6+ and 
CD4-CD6’ cells using YTS169.4 (antiCD8; rat y2b) and complement. 
The responsiveness of peripheral T cells was also investigated follow- 
ing their enrichment by passage over nylon wool as described (Julius 
et al., 1973). Thymocytes or T cells were washed and plated at 2 x lo5 
cells per well of a microtiter plate in the presence of varying concentra- 
tions of Acl-9 and 5 x IO5 mitomycin C-treated PUJ splenocytes. 
Proliferation was assessed by pulsing with PHETdR after 24 hr and 
measuring its incorporation a further 24 hr later. 
Flow Cytometry 
Thymocytes were obtained by gently teasing thymi from mice treated 
intraperitoneally with peptide in PBS. Released thymocytes were 
washed in PBS containing 1% fetal calf serum and 2 mM NaN3 (wash- 
ing solution) and were stained for expression of CD4 and CD6 using 
phycoerythrin (PE)-conjugated YTS191 .I (rat y2b; Caltag) and fluores- 
cein isothiocyanate (FITC)-conjugated MS1 69.4 (rat y2b). Expression 
of a third marker was assessed by the addition of either biotinylated 
F23.1 (anti-V56.2; mousey2a)orbiotinylated H1.2F3(anti-CD69; Phar- 
Mingen), binding of either monoclonal antibody being visualized by 
the addition of streptavidin-Tricolor (Caltag). All incubations were of 
40 min duration and were performed at 4OC on ice. Thymocytes were 
fixed in washing solution containing 1% formaldehyde (BDH) and were 
analysed on a Becton Dickinson FACSort using Lysys II software. 
Thymocytes were gated first according to their forward and side scat- 
ter characteristics and 10,000 events were acquired for phenotypic 
analysis, 
Competition Peptide Binding Assay 
The I-Au-expressing B cell hybridoma, PL-6 (Wraith et al., 1991) was 
distributed into the wells of a 96-well round-bottomed plate and resus- 
pended in medium containing serial dilutions of the peptide probe, 
Biol-9(4Y] and a fixed concentration of competitor peptides. Cells 
were incubated at 37OC for 16 hr before being washed and incubated 
on ice for 40 min with ExtrAvidin-FITC (Sigma). Samples were ana- 
lyzed by flow cytometry and the percentage inhibition of peptide bind- 
ing calculated following subtraction of background fluorescence. 
Studies of Apoptosis 
The extent of DNA fragmentation was assessed by sampling thymo- 
cytes from mice treated 16 hr earlier with peptide analogs of Acl-9 
or the negative control peptide 64-96. Thymocytes (lob) were incu- 
bated for 2 hr at 55°C in 20 ul of lysis buffer containing 10 mM EDTA, 
50 mM Tris-HCI (pH 7.5) 0.5% sodium lauryl sarkosinate, and 0.5 
mg/ml of proteinase K (Stratagene). Samples were briefly warmed to 
70°C, mixed with loading buffer containing 0.5% agarose, and loaded 
into dry wells of a 2% agarose gel. 
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